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Abstract 
A highly sensitive and selective capacitive aptasensor for detecting the malaria biomarker, 
Plasmodium falciparum glutamate dehydrogenase (PfGDH), directly in human serum 
samples is reported here. A thiolated ssDNA aptamer (NG3) that binds specifically to PfGDH 
with high affinity (Kd = 79 nM) was developed through a SELEX procedure. The aptamer 
was used for the development of an aptasensor against PfGDH using a non-Faradaic 
electrochemical impedance based signal transduction technique by monitoring the 
capacitance response at a frequency of 2 Hz. The aptasensor exhibited a wide dynamic range 
of 100 fM - 100 nM. The limits of detection obtained for the aptasensor were 0.43 pM in 
buffer and 0.77 pM in serum samples. Significantly low interferences from other predominant 
malarial biomarkers, namely, Plasmodium falciparum –lactate dehydrogenase and -histidine 
rich protein-II spiked serum samples were displayed by the aptasensor. This PfGDH 
aptasensor with highly sensitive and label free detection capability has great application 
potential for diagnosis of asymptotic malaria and monitoring the regression of malaria during 
treatment regime with antimalarial drugs. 
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Introduction 
Malaria is an infectious disease that occurs mostly in tropical and sub-tropical regions of the 
planet (Margaret et al., 2017). The World Health Organization (WHO) reported that half of 
the total malaria related deaths occurred in the year 2015 were caused solely by the infection 
of the Plasmodium falciparum species (World Health Organization, 2016). Malaria is a 
curable disease provided an appropriate diagnosis and linked follow-up treatment for the 
suspected persons are offered on time. Till date microscopic investigation is considered as the 
gold standard method for malaria diagnosis. Several other methods such as ELISA, buffy 
coat analysis, nucleic acid amplification and rapid diagnostic test (RDT) are also utilized and 
show good sensitivity (Tangpukdee et al., 2009). However, all these methods, except RDTs, 
are difficult to employ in point of care (POC) settings and resource limited environments due 
to requirement of expensive equipment and skilled operators (Morassin et al., 2002). Most of 
the RDTs for malaria employed in POC are antibody based and thus, have their own sets of 
limitations such as poor stability in hot and humid climates, exhibit variable results and do 
not offer quantification of parasitic load, which could lead to misdiagnosis (Jorgensen et. al., 
2006, Erdman and Kain, 2008). 
Over the last decade, aptamers are evolved as potential next generation biorecognition 
molecules for analytical applications. Nucleic acid aptamers are short chain oligonucleotides 
which can bind to a target molecule with high selectivity and sensitivity. ssDNA aptamers 
offer several advantages over antibodies such as ease of large scale production at low cost 
following in vitro chemical protocol, high thermal stability and long shelf-life, compatible 
chemistry to immobilize over sensor surfaces and scope to enhance their performance factors 
through chemical modifications (Kakoti and Goswami 2017; Cheung et al., 2013).  
For malaria diagnosis, various biomarker proteins like lactate dehydrogenase (LDH), 
histidine rich protein (HRP-II), aldolase, and glutamate dehydrogenase have been explored 
(Jain et al., 2014). Most of the RDTs available for the detection of Plasmodium falciparum 
(Pf) are based on PfHRP-II as the target antigen. However, reports claim that there are 
deletions of the PfHRP-II gene in some of the African and Asian regions (Murillo et al., 
2015; Viana et al., 2017), which prompted to explore other available biomarkers for 
developing reliable detection device for the parasite Plasmodium falciparum. The 
Plasmodium falciparum glutamate dehydrogenase (PfGDH) is recognised as a powerful 
malaria biomarker as it is considerably different from the host GDH in terms of structure, 
sequence, location and enzyme kinetics (Werner et al., 2005; Zaganas et al., 2009). It is 
present only in detectable amounts in the serum of Plasmodium falciparum infected patients 
(Li et al., 2005; Seol et al., 2017). 
Electrochemical impedance spectroscopy (EIS), either in Faradaic or non-Faradaic modes, 
has recently received enormous interest in the field of biosensors due to its highly sensitive 
signal transduction feature (Wang et al., 2017; Rohrbach et al., 2012). In non-Faradaic EIS 
measurements, variations in interfacial capacitance developed by dislocating water molecules 
and ions away from a bio-functionalised electrode surface after its binding to the target 
molecule is used for sensor application (Tkac and Davis, 2009). Furthermore, non-Faradaic 
EIS measurements are label-free, simple, and direct allowing the measurement of the target 
molecule in undiluted serum making it suitable for point of care applications (Arya et al., 
2018, Luo et al., 2013).  
Herein, a PfGDH ssDNA aptamer selected through systemic evaluation of ligand exponential 
enrichment (SELEX) process was immobilized chemically over an electrode surface through 
a self-assembled technique. The developed aptasensor was then utilized for detecting PfGDH 
directly in serum samples using non-Faradaic EIS technique. The aptasensor shows great 
sensitivity, specificity and dynamic range 
Materials and Methods 
Materials  
Dibasic/mono basic phosphate buffer, MgCl2, NaCl, KCl, alumina powder (50 nm coarse 
size), PCR kit, streptavidin magnetic beads, human serum albumin (HSA) and human serum 
from AB positive male were procured from Sigma Aldrich. Starting blocking buffer, H2SO4 
and Top 10 competent cells were procured from Thermo Fisher. The single stranded random 
N40 oligonucleotide DNA library with conserved primer binding site and primer were 
received from IDT technology (USA). All the proteins (PfGDH, HGDH, PfLDH and PfHRP-
II) used in the present investigation were previously cloned, expressed and characterised in 
house (Chakma et al., 2016; Goswami et al., 2016; Jain et al., 2016). Thiolated HPLC grade 
purified PfGDH aptamer NG3 and NG51 (see Table 1) were obtained from Sigma (UK). 
Table 1. Thiolated NG3 and NG51 aptamer sequences. 
Aptamer Sequences (5’→3’) 
NG3 SH-(CH2)6-TTT TCA CCT CAT ACG ACT CAC TAT AGC GGA TCC GAG 
CCG GGG TGT TCT GTT GGC GGG GGC GGT GGG CGG GCT GGC TCG 
AAC AAG CTT GC 
NG51 SH-(CH2)6-TTT TCA CCT CAT ACG ACT CAC TAT AGC GGA CCC CAC 
TCA CTG CTC GGA CTC TCC CCC TCC CCG CCT GGC TCG AAC AAG 
CTT GC 
 
Aptamer selection and screening  
The development of the aptamer against PfGDH was done through SELEX process. The 
ssDNA aptamer was developed from random oligonucleotide library in which a random 40-
nucleotide region (Fw-N40-Rev) was flanked by conserved primer binding site for 
amplification. A polyvinylidene difluoride (PVDF) membrane was used for PfGDH 
immobilization. Probable aptamer candidates were cloned at the end of 17 rounds of SELEX 
into pGEMT easy vector and transformed into E.coli DH5α cells. The transform cells were 
selected by blue-white screening and restriction digestion. The positive clone was sequenced 
and the secondary structure was predicted through Mfold online software (Zuker, 2003).  
Aptamer binding affinity measurement 
A surface plasmon resonance (SPR) study was performed for the measurement of the 
dissociation constant (Kd value) of the developed aptamer against PfGDH using a Reichert 
SPR 7000DC (USA) dual channel flow spectrophotometer at 25 °C over 50 nm gold coated 
chips (Reichert Technology, USA). The SPR chip was first cleaned with piranha solution (3:1 
H2SO4: H2O2) for 20 s, then washed with milli-Q water (18.2 MΩ.cm, Millipore, UK) for 5 
min followed by purging with N2 gas jet for drying. The chip was then incubated overnight 
with thiolated aptamer (1 µM) along with 6-mercapto 1-hexanol (MCH, Sigma) in a ratio of 
1:100 in binding buffer, followed by backfilling the surface with 1 mM MCH for 1 h 
(Aliakbarinodehi et al., 2017; Green et al., 2000). All the protein solutions and buffer were 
filtered through a 0.2 µm filter and degassed for 2 h. After obtaining a stable buffer SPR line, 
different concentrations of PfGDH and control protein were flowed over the aptamer 
modified SPR chip at 25 µl/min for 10 minutes, followed by 5 min of a dissociation step with 
buffer to remove any unbound proteins.   
Sensor fabrication  
Bare gold disc electrodes of 3 mm diameter (CHI Instruments, USA) were cleaned with 
piranha solution (3:1 ratio of H2SO4: H2O2) for 30 s, followed by mechanical polishing with 
50 nm course size alumina slurry (Sigma) for 5 min over a polishing pad (BASi, USA). The 
electrodes were then sonicated in absolute ethanol and milli-Q water for 5 min each, 
sequentially. Thereafter electrodes were electrochemically cleaned in 0.5 M H2SO4 by cycling 
the potential between -0.5 and +1.3 V versus Hg/Hg2SO4 till a stable characteristic reduction 
current peak of bare gold was observed. The electrodes were rinsed with ample amounts of 
milli-Q water and then dried in N2 gas jet steam.  
The aptamers were then grafted to the clean gold electrodes following a previously reported 
method (Jolly et al., 2017). In brief, 100 mM of MCH was first prepared in absolute ethanol 
as stock solution and then diluted to 1 mM in binding buffer (10 mM potassium phosphate 
buffer pH 8.0 with 5 mM NaCl, 5 mM KCl and 2.5 mM MgCl2). The aptamer was heat 
treated at 90 °C for 5 min then cooled down to room temperature (RT) for 15 min before 
initiating the sensor fabrication. The clean electrodes were incubated in 200 µl of PfGDH 
specific aptamer: MCH in a 1:100 ratio and left overnight in a humidity chamber. After 
immobilization, the electrodes were rinsed with milli-Q water to remove unbound aptamers. 
To ensure proper coverage, the electrodes were further treated with 1 mM MCH for 1 h. The 
electrodes were again washed with milli-Q water and dried with N2 steam and blocked with 
starting blocking buffer (Thermo Fisher, UK) for 30 minutes to prevent non-specific 
attachment of proteins over the electrodes.   
EIS measurement.  
Non-Faradaic EIS measurements were performed using a µAutolab III / FRA2 potentiostat 
(Metrohm) in a two-electrode setup consisting of aptamer functionalised gold disc electrode 
as working electrode and Ag/AgCl as reference electrode. The measurements were performed 
in binding buffer, applying a 10 mV a.c. amplitude voltage in the frequency range 1 MHz to 
100 mHz. After obtaining a stable signal in the measurement buffer, the electrodes were 
incubated with varying concentrations of PfGDH protein in 200 µl binding buffer for 30 min, 
following which the EIS spectra were recorded after washing the electrodes with buffer. The 
specificity of developed aptasensor was tested with other malaria biomarker proteins such as 
Plasmodium falciparum lactate dehydrogenase (PfLDH), Plasmodium falciparum histidine 
rich protein-II (PfHRP-II) and analogous human glutamate dehydrogenase (HGDH) and 
HSA. 
Results and Discussion 
Aptamer screening and characterization  
The single stranded DNA aptamer for PfGDH was selected from a 1014-15 random ssDNA 
oligonucleotide library through SELEX procedure. The PVDF membrane was used as the 
matrix support during the SELEX procedure for protein immobilization. The protein 
molecule was attached in a random orientation via integration of dipole and hydrophobic 
interactions over the PVDF membrane (Matsudaira, 1987), which provides multiple aptatope 
surface for aptamer binding (Jain et al., 2016). For the selection of aptamer, a total of 17 
rounds of SELEX cycle were performed, of which 3 counter SELEX cycle against PVDF 
membrane and 2 rounds of negative SELEX cycle with HGDH were performed to eliminate 
non-specific aptamers candidates (Figure 1). After the final round of PCR amplification of 
the isolated ssDNA candidate from the SELEX cycle, the amplicons were cloned, sequenced 
and aligned through Clustal X software. The alignment results showed that some sequences 
were enriched more during the process and out of those two candidates (NG3, NG51) with 
highest enrichment were finally selected (Supplementary Information, Figure S1). The 
secondary structures of the aptamers NG3, NG51 were determined by Mfold (Figure 2). 
The selected 5’ end thiol modified aptamers were immobilized (~200 nmol) over SPR chips 
followed by backfilling / blocking with MCH. The prepared electrodes were then utilized for 
detection of different concentration of PfGDH and other non-specific proteins. The binding 
of PfGDH over the gold chip surface led to an increase in SPR angle, reaching a stabilization 
plateau within less than 10 mins. After binding, buffer solution was passed over the surface to 
remove loosely bound protein from the surface. The amount of PfGDH attached to the SPR 
chip was calculated by recording the difference between the final and initial SPR angle 
(Figure 1A, B). The specificities of the developed aptamers were analysed by testing control 
proteins (HGDH, PfLDH, HSA), which showed negligible changes in SPR angle for both the 
NG3 and NG51 aptamers (Supplementary Information, Figure S2). The binding affinities of 
the developed aptamers were calculated using the single ligand binding site equation in 1:1 
interaction mode, X+Y=XY, where X is injected target protein and Y is immobilized aptamer 
molecule, XY is aptamer–protein complex formed over the SPR chip. The formation of 
aptamer–protein complex (XY) is directly proportional to the response unit (RIU) of SPR 
(Scarano et al., 2010). The dissociation constant (Kd) values for the aptamers were calculated 
using the equation RIU=RIUmax*c/(Kd+c), where c is the protein concentration. The Kd were 
determined as 79.16 ± 1.58 nM and 370 ± 14.39 nM for NG3 and NG51, respectively. The 
Gibbs energy, δG = - RT ln Ka, where R is the universal gas constant, T is temperature and Ka 
= 1/Kd, was also calculated for the NG3 and NG51 aptamers at 298 K and found to be - 56.9 
kJ/mol and - 36.7 kJ/mol, respectively. The negative Gibbs energy values indicate the prompt 
interaction of PfGDH with aptamer over the solid surface platform of the SPR chip, and 
found to be better for NG3 aptamer candidate. Based on the higher binding affinity against 
PfGDH and lower Gibbs energy change, NG3 was considered for further study. 
Sensor surface characterization  
The sensor fabrication process over the bare gold electrodes was characterized by atomic 
force microscopy (AFM) and cyclic voltammetry (CV). The results of AFM characterization 
were done in continuous tapping mode. The topographic average roughness analysis using 
wsxm 5.0 software analysis showed gradual decrease of roughness from bare gold (1.52 nm) 
to aptamer modified gold electrode (1.41 nm) and blocked aptasensor electrode (1.33 nm). 
This was accompanied by an increase in the average height of the surface modified 
electrodes, indicating the binding of aptamer and blocking reagents over the electrode (Figure 
3A-C). CV was performed to investigate the layer by layer modification of the electrodes. 
The results depict the quasi reversible cyclic voltammogram of [Fe(CN)6]
3-/4- with a decrease 
in oxidation and reduction currents of the modified electrodes compared to the blank gold 
electrode (Figure 3D). The formation of a self-assembled monolayer of aptamer-MCH over 
the gold electrode led to an increase in ΔEp (difference between oxidation and reduction 
potentials) and lowered the redox current. This could be attributed to the charge repulsion 
caused by the negative phosphate backbone of the aptamer (Bang et al., 2005) as well as the 
passivation of the electrode hindering the electron transfer. The results suggest successful 
assembly of the aptamer over the electrode surface. After blocking of aptamer/MCH 
electrode with the starting blocking buffer, a further decrease in redox current was observed 
due to void spaces of gold and/or MCH being occupied by non-conducting moieties of the 
blocking buffer.  
Detection of PfGDH  
The NG3 aptamer was used for PfGDH sensing following non-Faradaic impedance 
measurements without using any redox marker in the solution. In this mode, high values of 
impedance were observed and variations in the capacitance of the system that occurred due to 
the binding of the aptamer with the target protein were measured. The capacitive response of 
the sensor was discerned by measuring 1/ωZ’’, where ω is the angular frequency and Z’’ the 
imaginary part of the impedance of the system. A maximum in the phase angle was observed 
at ~2 Hz, indicating maximum capacitive response at this frequency (Figure 4A). This 
frequency was thus used for plotting the dose response of the capacitive variation signal. The 
reduction in capacitance with increasing concentrations of PfGDH indicates successful 
binding of the target molecule with the NG3 aptamer (Figure 4B, C). The change in 
capacitance is attributed to the alteration in dielectric properties of the biolayer through the 
replacement of solvated ions and water molecules by the protein, as well as due to the 
increase in thickness of the biolayer upon protein binding (Arya et al., 2018; Liu et al., 2017). 
The limit of detection (LOD) (3x standard deviation of blank/slope of calibration curve) of 
PfGDH was found to be 0.43 pM in the buffer, with a linear (in log scale) detection range of 
100 fM to 100 nM (Figure 4D).  
The capacitive aptasensor was then tested directly in undiluted blood serum with spiked 
PfGDH. The PfGDH protein with different concentrations that fall within the dynamic range 
obtained in the buffer medium (100 fM - 100 nM) was used in the undiluted serum (Figure 
5). This range covers the previously reported PfGDH concentrations used (2 to 16 nM) for 
malaria diagnosis through an immuno-chromatographic dipstick based method (Djadid et al., 
2014; Li et al., 2005). Like in buffer, a maximum phase angle was observed at ~2 Hz during 
the measurement of serum spiked PfGDH protein (Figure 5A). The capacitance at 2 Hz was 
therefore considered further for plotting the calibration curve (Figure 5B). The detection in 
serum followed a linear dependency (in log scale) for the whole range and an LOD of 0.77 
pM for PfGDH was discerned (Figure 5C). The results indicate a comparable signal 
sensitivity of the aptasensor between samples in buffer and serum media, which validate a 
conducive microenvironment for the interaction of the aptamer with the target antigen protein 
in the serum medium (Park et al., 2012). The binding between PfGDH and NG3 aptamer over 
electrode was probably caused by the interaction between some positively charged PfGDH 
amino acid and negatively charged ssDNA aptamer. The net surface charge of aptamer-
protein complex governed the dielectric property over the sensing surface of electrode which 
was not affected by the ionic microenvironment in serum in the present case (Cole and Cole, 
1941; Pethig and Kell, 1987). The interferences from the other prominent malaria biomarker 
proteins (PfLDH and HRP-II) that are likely to be secreted during the malaria condition were 
examined by spiking these proteins in undiluted serum (Figure 5D). The responses were 6.5% 
(PfLDH) and 0.5% (PfHRP-II) of the control protein (PfGDH) for the corresponding proteins 
shown in the parentheses. The results indicate only a minor non-specific interaction of the 
sensor with the PfLDH protein. The sensitive response profile obtained directly on the serum 
sample indicates that the serum components including HGDH and the predominant serum 
protein, HSA do not significantly interfere with the aptasensor function. Hence the proposed 
sensor has potential to be developed as a practical sensor for malaria diagnosis. 
Conclusion 
Herein, a reagent-free and label-free aptasensor for diagnosis of malaria using non-Faradaic 
EIS has been demonstrated. This is the first report on PfGDH aptasensor exploiting non-
Faradaic impedance technique as signal transduction platform. A sensitive aptamer (NG3) 
was developed through a screening technique and rational approach. A significantly low 
dissociation constant (Kd=79 nM) discerned for the aptamer–PfGDH interaction validates its 
strong binding affinity towards the target antigen. The stable chemical immobilization of the 
aptamer over the electrode surface through SAM approach offered additional advantages of 
easy and reproducible fabrication of the aptasensor. The broad detection range and ultra-low 
limit of detection enables the sensors to be used for diagnosis of asymptomatic malaria and 
monitoring the regression of malaria during treatment regime with antimalarial drugs. 
Overall, this simple, redox free, robust and highly sensitive non-Faradaic capacitance-based 
aptasensor for PfGDH has great application potential for diagnosis of malaria using untreated 
and undiluted serum samples in POC settings. 
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Figures 
 
Figure 1. Fabrication of electrode with aptamer and detection of PfGDH, development of 
aptamer through SELEX.  
 Figure 2. SPR sensogram for NG3 (A) and NG51 (B) with different concentration of PfGDH. 
Plotting of sensogram data for determination of dissociation constant (Kd) for (C) NG3 and 
(D) NG51. Inset secondary structure of NG3, NG51 aptamer along with δG values.  
 Figure 3. AFM images of (A) bare gold electrode (B) surface assembled monolayer with 
aptamer-MCH over gold electrode (C) surface blocking with MCH and blocking buffer over 
aptamer modified electrode. (D) CV of the electrodes recorded by using Ag/AgCl as 
reference electrode. Scan rate of 50 mV/s in 10 mM potassium hexacyanoferrate solution 
prepared in PBS.  
 
 Figure 4. Non-Faradaic measurement in buffer (A) Phase response vs frequency, (B) 
Capacitance response of NG3 aptamer-PfGDH with circled enlarged image in inset. (C) 
Enlarged image of circled region of capacitance responses. (D) Calibration curve of 
capacitance response at 2 Hz versus log PfGDH concentrations spiked in buffer. 
 
 Figure 5. (A) Non-Faradaic measurement in undiluted serum Phase response vs frequency. 
(B) Capacitance response of NG3 aptamer-PfGDH with circled enlarged image in inset. (C) 
Calibration curve of capacitance response at 2 Hz verses log PfGDH concentrations spiked in 
undiluted serum. (D) Response of NG3 aptamer with analogue proteins each with 100 nM 
spiked in serum. 
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